|
藥明生物技術有限公司, 02269.HK - 財務比率 |
2023-12 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
變現能力分析 |
流動比率(倍) |
2.78 |
1.98 |
2.37 |
3.16 |
3.37 |
4.36 |
3.8 |
1.04 |
0.5 |
0.88 |
速動比率(倍) |
2.54 |
1.74 |
2.16 |
2.92 |
3.23 |
4.18 |
3.63 |
0.94 |
0.46 |
0.75 |
償債能力分析 |
長期債項/股東權益(%) |
9.5 |
8.42 |
6.41 |
12.18 |
13.0 |
0.0 |
0.0 |
331.15 |
0.0 |
0.0 |
總債項/股東權益(%) |
11.31 |
12.62 |
13.31 |
16.2 |
17.16 |
0.0 |
0.0 |
417.59 |
312.23 |
14.9 |
總債項/資本運用(%) |
9.32 |
10.99 |
12.01 |
13.62 |
14.89 |
0.0 |
0.0 |
95.38 |
294.51 |
14.75 |
投資回報分析 |
股東權益回報率(%) |
8.43 |
12.61 |
10.5 |
8.21 |
7.93 |
7.89 |
6.28 |
52.17 |
30.49 |
11.29 |
資本運用回報率(%) |
6.95 |
10.98 |
9.47 |
6.9 |
6.88 |
7.81 |
6.24 |
11.92 |
28.75 |
11.17 |
總資產回報率(%) |
6.01 |
8.92 |
7.7 |
5.83 |
5.76 |
6.71 |
5.21 |
7.11 |
3.28 |
6.59 |
盈利能力分析 |
經營利潤率(%) |
24.5 |
35.09 |
38.81 |
34.98 |
28.36 |
29.11 |
18.76 |
17.78 |
11.74 |
14.77 |
稅前利潤率(%) |
24.5 |
35.09 |
38.81 |
35.03 |
28.28 |
29.11 |
18.76 |
17.78 |
11.74 |
14.77 |
邊際利潤率(%) |
19.96 |
28.95 |
32.93 |
30.09 |
25.45 |
24.88 |
15.61 |
14.27 |
7.99 |
12.65 |
營運能力分析 |
存貨周轉率(倍) |
9.65 |
6.69 |
6.1 |
5.18 |
9.97 |
11.16 |
11.94 |
12.52 |
11.16 |
9.89 |
投資收益分析 |
派息比率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
相關統計 |
財政年度周最高價 |
77.4 |
94.65 |
148.0 |
102.8 |
100.5 |
98.5 |
49.25 |
0.0 |
0.0 |
0.0 |
財政年度周最低價 |
26.6 |
35.0 |
73.65 |
28.783 |
44.5 |
43.4 |
25.0 |
0.0 |
0.0 |
0.0 |
財政年度最高市盈率(倍) |
86.11 |
79.15 |
149.22 |
200.58 |
109.67 |
166.36 |
171.16 |
0.0 |
0.0 |
0.0 |
財政年度最低市盈率(倍) |
29.59 |
29.27 |
74.26 |
56.16 |
48.56 |
73.3 |
86.89 |
0.0 |
0.0 |
0.0 |
財政年度最高週息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度最低週息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
|